
NORWAY - NeoMed's Clavis Pharma to go public
Clavis Pharma ASA has applied for listing on the Oslo Stock Exchange and plans to go public this summer. The company, which is backed by NeoMed, plans to conduct an IPO in the order of NOK 200m. The present largest shareholders intend to participate with further investments in the IPO.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater